Johnson & Johnson (JNJ) Tops Q3 EPS by 10c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Johnson & Johnson (JNJ) Declares $0.84 Quarterly Dividend; 2.4% Yield
October 19, 2017 6:55 AM EDTJohnson & Johnson (NYSE: JNJ) declared a quarterly dividend of $0.84 per share, or $3.36 annualized.
The dividend will be payable on December 12, 2017, to stockholders of record on November 28, 2017, with an ex-dividend date of November 27, 2017.
The annual yield on the dividend is 2.4 percent.
For a... More
Johnson & Johnson (JNJ) PT Raised to $145 at Morgan Stanley
October 18, 2017 7:49 AM EDTMorgan Stanley raised its price target on Johnson & Johnson (NYSE: JNJ) to $145.00 (from $140.00) while maintaining a Overweight rating.
... MoreJohnson & Johnson (JNJ) PT Raised to $161 at Jefferies
October 18, 2017 7:30 AM EDTJefferies raised its price target on Johnson & Johnson (NYSE: JNJ) to $161.00 (from $160.00) while maintaining a Buy rating following beat and raise results.
Analyst Jeffrey Holford notes their revenue and adjusted EPS estimates remain well above consensus.
"The Pharma division remains under-modeled by... More
Johnson & Johnson (JNJ) PT Raised to $165 at Leerink Partners
October 18, 2017 7:03 AM EDTLeerink Partners raised its price target on Johnson & Johnson (NYSE: JNJ) to $165.00 (from $150.00) while maintaining a Outperform rating.
Analyst Danielle Antalffy said outperformance highlights momentum. 217/2018 outlook moves higher.
... MoreJohnson & Johnson (JNJ) PT Raised to $142 at Stifel on 3Q Earnings Report; 'Pharma Carries the Day, Hurricane Headwinds Encouragingly Modest
October 17, 2017 5:16 PM EDTStifel raised its price target on Johnson & Johnson (NYSE: JNJ) to $142.00 (from $140.00) while maintaining a Hold rating, following the company's third quarter earnings report.
Analyst Rick Wise notes a positive outlook, as the company reported third quarter earnings per share and revenue results above... More
